Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Innova Biosciences Introduces InnovaGOLD Nanoparticles
Thursday, August 28, 2014
New ultra-high quality gold nanoparticles simplify assay development and improve the sensitivity of immunoassays.

Exquisite ‘Made-to-Measure’ Phospho-Specific Polyclonal Antibodies
Thursday, August 21, 2014
AMSBIO’s antibody production service is reliable and produces high quality product.

Bio-Rad Introduces SureBeads™ Magnetic Bead IP System
Thursday, July 31, 2014
A high-performance immunoprecipitation system at an affordable price.

Siemens Unveils New Chemistry and Immunoassay Systems
Thursday, July 31, 2014
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

Lophius Biosciences Launches Interactive T CELL TOOLS Product Finder
Thursday, July 17, 2014
New T CELL TOOLS product line with Company’s new e-commerce online order portal.

Bio-Rad Introduces Bio-Plex Pro™ RBM Human Metabolic and Hormone Assays
Thursday, July 17, 2014
Developed in partnership with Myriad RBM, Inc., these multiplex immunoassays permit robust and simultaneous quantification of a highly relevant set of protein biomarkers for the study of diabetes, obesity, and metabolic syndrome, as well as related conditions such as cardiovascular disease and inflammation.

Method Separates Oxidized Monoclonal Antibody (MAb) Species
Friday, July 04, 2014
Thermo Scientific™ ProPac™ HIC-10 column used to separate the papain fragments.

Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)
Wednesday, July 02, 2014
Company will launch the product at annual meeting of the AACC on July 28th 2014.

GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 358
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv